$SRAX Positioned to Satisfy Modern Consumers’ Desire for Data Monetization, Protection

• In exclusive interview, CEO discusses how SRAX revolutionizes consumer data collection
• SRAX committed to building the most valuable opted-in data set in the world
• Company poised to capitalize on surge of multibillion-dollar data monetization market

In an exclusive interview at the LD Micro Main Event 2019, SRAX Inc. (NASDAQ: SRAX) Founder and CEO Christopher Miglino discussed how SRAX has revolutionized consumer data collection through BIGtoken, its proprietary, secure and transparent platform. The platform enables consumers to own and monetize their data as they earn rewards when they opt into the data sharing, as well as each time their data is purchased and each time they bring a new user to the platform.

With 16.4 million users worldwide, and three to five thousand new users joining each day, BIGtoken may be the most valuable opted-in data set in the world, said Miglino during the interview with SNN’s Robert Crafton…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$JMDA Launches New Challenges Feature on Vocal

$GNPX New Therapies For Pancreatic Cancer, a Big Boon for Biotechs

January 22, 2020

Palm Beach, FL –January 22, 2020 – Pancreatic cancer is a notoriously aggressive and hard-to-treat malignancy; the five-year survival rate is less than 10%. Treatment options for pancreatic cancer are limited to surgery, radiation, and chemotherapies; thus, demand is high for safer, more-efficacious drugs, which will serve to drive the market. ResearchAndMarkets projects that the global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025. The growth of the pancreatic cancer therapy market is primarily attributed to the increase in number of therapies launched in the market. The development of new drugs is thus expected to drive the growth of pancreatic cancer therapy market.  The report continued by saying: “However, these drugs travel throughout the body and thus can affect normal and healthy cells adversely. Blood-forming cells in the bone marrow, hair follicles and cell in the mouth, digestive tract, and reproductive system are likely to be affected by chemotherapeutic drugs. The current treatment options available for pancreatic cancer patients only help to extend the patients’ lives by a few months.    Active biotech and pharma companies in the markets this week include Oncolytics Biotech^® Inc. (NASDAQ: ONCY) (TSX: ONC), Mallinckrodt plc (NYSE: MNK), Genprex, Inc. (NASDAQ: GNPX), Soligenix, Inc. (NASDAQ: SNGX), BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX).

“This demands potential drugs that are able to enhance the effectiveness of chemotherapy drugs. Combination of two or more chemotherapy drugs are a suitable way out to increase the efficacy of the drug as well as proves advantageous in the treatment… the biologic therapy segment is expected to grow at the fastest rate during the coming years owing to increasing number of novel upcoming immunotherapies as well as targeted cell therapy that treats the cancer without any severe side effects and has number of therapeutic benefits over the conventional chemotherapies… This demands potential drugs that are able to enhance the effectiveness of chemotherapy drugs. Combination of two or more chemotherapy drugs are a suitable way out to increase the efficacy of the drug as well as proves advantageous in the treatment.”

Oncolytics Biotech^® Inc. (NASDAQ: ONCY) (TSX: ONC) BREAKING NEWS:  Oncolytics Biotech^® Announces Publication of an Abstract for the 2020 Gastrointestinal Cancers Symposium Highlighting CEACAM6 as a Potential Prognostic Biomarker Candidate for Pancreatic Cancer  – Oncolytics Biotech^® currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today stated that the previously announced abstract for a poster to be presented at the 2020 Gastrointestinal Cancers Symposium sponsored by ASCO in San Francisco, has been published.  The abstract highlights new biomarker data from the randomized study NCI 8601:  Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer.

The abstract, CEACAM6 is a candidate biomarker for Reolysin^® (pelareorep) sensitivity in pancreatic adenocarcinoma (PDAC), was co-authored by Dr. Anne Noonan, Department of Medical Oncology, Ohio State University Wexner Medical Center, Richard Solove Research Institute and James Cancer Hospital, and Dr. Tanios Bekaii-Saab Senior Associate Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona.

Data in the abstract associate low levels of the gene CEACAM6 with prolonged progression free survival (PFS) in pelareorep-treated patients with pancreatic cancer, with PFS improving from 5.72 months to 10.32 months (p=0.05). This effect was not seen in non-pelareorep treated patients. Consequently, CEACAM6 may serve as a prognostic biomarker for sensitivity of pancreatic tumors to pelareorep treatment.  Additional data will be announced following the poster presentation.      Read this full press release and more news for ONCY at:  https://www.financialnewsmedia.com/news-oncy/    

Other recent developments in the biotech industry include:

Mallinckrodt plc (NYSE: MNK) a global biopharmaceutical company, recently confirmed enrollment of the first patient in the company’s Phase 4, multi-center, multiple-dose, open-label study to assess the effects of Acthar Gel as a therapy option in patients with severe keratitis.

“In my experience, a considerable number of severe keratitis patients can have persistent disease that may not be resolved by first-line treatment,” said Eugene McLaurin, MD and Fellow, American Academy of Ophthalmology and American College of Surgeons. “I am pleased that the first patient has been enrolled in this important Phase 4 study, the results of which may potentially provide data to further support Acthar Gel as a treatment option in appropriate keratitis patients.”

Genprex, Inc. (NASDAQ: GNPX) a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, recently announced that the U.S Food and Drug Administration (FDA) has granted Fast Track Designation for Genprex’s Oncoprex™ immunogene therapy in combination with EGFR inhibitor osimertinib (AstraZeneca’s Tagrisso®, which had worldwide sales in 2018 of $1.86 billion, $2.31 billion in the first 9 months of 2019 and is currently AstraZeneca’s highest grossing product) for the treatment of non-small cell lung cancer (NSCLC) patients with EFGR mutations that progressed after treatment with osimertinib alone. Oncoprex is comprised of the TUSC2 (Tumor Suppressor Candidate 2) gene complexed with a lipid nanoparticle. TUSC2 is the active agent in Oncoprex.

Genprex has treated more than 50 lung cancer patients with Oncoprex in Phase I and II clinical trials. The company believes the data from these trials are encouraging as to both safety and efficacy.

Soligenix, Inc. (NASDAQ: SNGX)  a late-stage pharmaceutical company working to improve the current standard of care for numerous rare diseases through the development and commercialization of novel treatments, is nearing the release of topline data after completing final enrollment for SGX301, a pivotal Phase 3 trial targeting the treatment of cutaneous T-cell lymphoma. A successful report may position the company for significant increases to shareholder value before the end of Q1 2020, and ultimately position the company to commercialize its first drug in a market that is estimated at a more than $200 million revenue opportunity.

The Phase 3 clinical trial is focused on the potential benefits of Soligenix’s topical drug ointment SGX301, or synthetic hypericin, in the treatment of cutaneous T-cell lymphoma (CTCL). CTCL is a rare type of Non-Hodgkin’s Lymphoma that sits high on the list of conditions that has no current or effective drug treatment, pushing Soligenix to fill the demand to serve this unmet medical need.

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) recently announced the appointments of Charles Gayer as chief commercial officer and Allen Hodge as vice president and general manager for the United States.

Mr. Gayer joined BioCryst in 2015 as vice president of global strategic marketing. Since July 2019 he has served as interim chief commercial officer, playing a key role in defining the strategy, and building the commercial operations, to support the launch of berotralstat, BioCryst’s oral kallikrein inhibitor for hereditary angioedema (HAE).

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech^® Inc.  by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$LXRP Inks Licensing Deal with Smokeless Cannadips CBD Product Maker

• Lexaria Bioscience is a company dedicated to developing effective oral ingestion methods for drug substances that rival the rapid-delivery qualities of more health-dangerous inhaled-drug products.
• Inhalation is a particularly popular method of using tobacco and cannabis products, despite government warnings about the scientifically established dangers of doing so
• Lexaria has been boosting its profile and revenue potential through licensing agreements with other companies
• Lexaria recently announced a licensing agreement with Cannadips CBD-maker The Boldt Runners Corporation
• The agreement grants Cannadips CBD use of Lexaria’s DehydraTECH IP to improve the speed of its effectiveness and to combat the throat irritation that can accompany use of terpene-rich multi spectrum oils

Drug product consumption innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has announced a trade agreement that continues to advance the company’s revenue-building efforts through licensing its technology to other product manufacturers that can benefit from Lexaria’s DehydraTECH™ oral drug delivery IP.

The agreement announced recently provides Cannadips CBD with exclusive access rights to Lexaria’s technology for the U.S. market for 10 years, granting the ‘Original Smokeless CBD Dip Brand’ Lexaria’s fast-acting, high-absorption technology with options to expand the license to Europe, Mexico, and Canada and to renew the license for an…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$YGYI Khrysos Industries, Inc. Secures $1.2M of Tolling Revenue for February

$SRAX Joins Forces with Experian to Offer Financial Services to BIGtoken Users

$GGBXF CBD Edibles Companies are Struggling to Keep up with Consumer Demand

January 21, 2020

Palm Beach, FL – January 21, 2020 — Thanks to Cannabis 2.0, companies are selling out of CBD edibles – and fast.  So much so, the Toronto Sun refers to it as “Edibles Madness.”  The Ontario Cannabis Store website, for example, saw so much demand, the site crashed several times, while soft-chew items like gummies sold out in less than a half hour.  Better, analysts at Deloitte, “The edibles market alone is estimated to be worth at least $1.6 billion a year in Canada, with cannabis-infused beverages adding a further $529 million,” said Jennifer Lee, a partner and Deloitte Canada’s Cannabis National Leader, and Consumer Advisory and Analytics Practice National Leader. “According to our research and stakeholder interviews, much of this economic boost will be on top of current cannabis product spending. The introduction of cannabis-infused edibles will clearly threaten the alcohol industry as consumers are using the product for similar usage occasions.”  That’s opening a wide range of opportunity for companies including Naturally Splendid Enterprises Ltd. (TSX-V:NSP)(OTCQB:NSPDF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF), Curaleaf Holdings Inc. (CSE:CURA)(OTCQX:CURLF), Green Thumb Industries Inc. (CSE:GTII) (OTCQX:GTBIF), and Green Growth Brands Inc. (CSE:GGB)(OTCQB:GGBXF).

Naturally Splendid Enterprises Ltd. (TSXV:NSP)(OTCQB:NSPDF) BREAKING NEWS: Naturally Splendid Enterprises Ltd. just provided the following updates and outlook for 2020. Naturally Splendid drives the majority of revenue from the Prosnack Division, manufacturing nutritional bars & bites from mainly plant-based ingredients at our Safe Quality Food Level 2 manufacturing facility (SQF2), forming the foundation to a sustainable and profitable business.  Purchase orders in January have already exceeded $300,000 CDN to date. The Company’s focus will be on expanding business and growing revenue in the plant-based nutritional category while the cannabis edibles markets continues the path to more mainstream opportunities. Naturally Splendid CEO Mr. J. Craig Goodwin states, “The Company continues to focus on increasing our nutritional, plant-based bars and bites business, expanding production capacity and efficiencies at our SQF2 food manufacturing facility. We remain confident the edibles market will continue to evolve into a lucrative opportunity. However, that market continues to be challenged by restrictive marketing and distribution regulations.

In comparison, the plant-based nutrition market shows current, mid-term and long-term growth. This past December, the investment firm UBS, reported  the plant-based nutrition market to be $4B USD in 2018, growing to $88B USD by 2030. With consistent messaging from the market supporting this significant forecast in sales growth, we have positioned the Company to become a leading developer and manufacturer of nutritional plant-based bars and bites through our Prosnack Division.  This strategic approach is building shareholder value as confirmed by a recent valuation that pegged the value of  Prosnack of $11.1M CDN. It is important to understand our strategy to develop our plant-based business has a synergistic relationship with CBD edibles. Our expertise as food manufacturers utilizing plant-based ingredients will be a driver for securing business in the evolving edibles market”.

Other cannabis-related developments from around the markets include:

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF) announced changes to streamline its leadership structure. The Company’s President, Mr. Csaba Reider, will be departing the organization. Mr. Reider’s duties will be assumed by the Company’s CEO, Brian Athaide. Mike Gibbons, Vice President of Sales, is also leaving the organization. Robert Gora, Vice President of Medical Commercialization, will assume the consolidated role of Vice President, National Sales, leading sales and revenue generation across medical and recreational channels. “The changes we announce today are part of a comprehensive review of our operations to reduce costs and improve cash flow. This will result in significant G&A savings and a leaner more efficient organization. We are also very focused on ramping up production, expanding our product portfolio with innovative organic products and gaining market share across the country.” commented Brian Athaide, CEO of TGOD.

Curaleaf Holdings Inc. (CSE:CURA)(OTCQX:CURLF) announced the upsizing and closing of a Senior Secured Term Loan Facility from a syndicate of lenders totaling US$300 million. The notes bear interest at a rate of 13.0% per annum, payable quarterly in arrears, with a maturity 48 months from closing. The proceeds will be used to refinance existing debt, satisfy transaction fees and expenses from previously announced acquisitions, fund capital expenditures and for general corporate purposes. The sole placement agent for the Facility is Seaport Global Securities LLC. “We are pleased with the upsizing and closing of the deal at what we believe to be attractive terms,” said Joseph Lusardi, Chief Executive Officer of Curaleaf. “Most importantly we strengthened our balance sheet without diluting our existing shareholders. With the completion of this transaction, we have ample liquidity to execute on our strategy and are well-positioned to take advantage of the significant market opportunities that exist in this space.”

Green Thumb Industries Inc. (CSE:GTII)(OTCQX:GTBIF) announced the next phase of its Social Equity License Education Assistance Program (LEAP) which includes programming and one-on-one consultations for Illinois craft grower, infuser and transporter licenses. Applications are due to the state on March 16 and the Department of Agriculture is expected to issue up to 40 craft grower licenses, up to 40 infuser licenses, and an unlimited number of transporter licenses on or before July 1, 2020. Dispensary applications were due January 2 with up to 75 awardees expected to be announced by May 1. “At GTI, we believe it is our responsibility to help reduce barriers to cannabis business ownership for minorities and others most impacted by the war on drugs – and we are so humbled to have provided guidance to more than 200 applicants so far, many of whom applied for dispensary licenses,” says GTI Senior Vice President of Government and Regulatory Affairs Dina Rollman. “LEAP was created to offer assistance to those looking to enter this highly competitive industry and to serve as a resource to as many applicants as possible that qualify as a social equity applicant under Illinois law. GTI has had a long history of winning licenses and our team is excited to share our lessons learned and best practices with a new generation of business owners in this burgeoning industry. We can’t wait to continue our work with the new round of applicants and those who are awarded licenses.”

Green Growth Brands Inc. (CSE:GGB)(OTCQB:GGBXF) shared statistics from its first full holiday season and from its second fiscal quarter ended December 28, 2019. Over 128,000 Seventh Sense Botanical Transactions were processed between Black Friday and December 28, 2019. Seventh Sense offered three holiday-exclusive items: the Pebble Lip Balm, Therapeutic Starter and the Lip and Body gift sets. Bestselling Seventh Sense products included the 1,500 mg Hyperstrength Cream, the Therapeutic Starter gift set and the Unwind Sleep Blend Roll-On. Over 85,000 consumers received a Seventh Sense direct mail piece detailing the product line and holiday offerings. The Seventh Sense customer database grew by 42% between Black Friday and December 28, 2019. As of December 28, 2019, the Company operates 195 mall-based Seventh Sense shops in 35 states, including 54 new shops that opened during second quarter fiscal 2020.  “Our ability to capitalize on the holiday shopping season is a reflection of our retail and operations expertise,” said Peter Horvath, CEO of Green Growth Brands. “We are pleased with the performance of both business segments and particularly excited by the consumer demand signals we saw in CBD.  We have brought together high-quality CBD, high-efficacy personal care formulations, familiar packaging, top-tier retail presentations, and fair, everyday-value prices to create products that consumers from all walks of life are really responding to.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM was compensated thirty five hundred dollars for news coverage of current press releases issued by as Naturally Splendid Enterprises Ltd.  by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$GNPX Receipt of FDA Fast Track Designation in Lung Cancer Immunogene Therapy

$YGYI Declaration of Monthly Dividend for 1st Quarter 2020

SAN DIEGO, Jan. 17, 2020 — Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:YGYIP) for each of January, February and March 2020.  The dividend will be payable on February 17, March 16 and April 15 2020 to holders of record as of January 31, February 28 and March 31 2020. The dividend will be paid in cash.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a multi-channel lifestyle company operating in 3 distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise.  The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI Investor Relations
800.504.8650
investors@ygyi.com

$SRAX Platform Leads the Way in Data Privacy

$PBIO Innovative UST Platform Featured in Leading North American Cannabis Publication

$POAI Aims to Commercialize AI-Driven Predictive Model of Ovarian Cancer in Q1 2020

$CNPOF $RIV $RIV.V Provides Update on Portfolio Companies

$PBIO Zacks Small Cap Research Issues Update, Maintains Price Target

$JMDA New Digital Media Model Helps Creators Build Audiences, Make Money

• The traditional digital media model was broken; Jerrick built a new one
• Jerrick’s proprietary Vocal platform gives content creators powerful storytelling, money-making, audience-building tools
• With over 500,000 Vocal creators and 8 million monthly visitors, Jerrick’s market penetration still in its early stages

In today’s digital world, demand for user-generated content is soaring. Every minute on the Internet, more than 4 million videos are viewed on YouTube. In that same minute, 1,440 WordPress posts are published, 481,000 tweets are sent, and 174,000 Instagram posts are viewed. These numbers are expected to only continue to rise. Jerrick Media Holdings Inc. (OTC: JMDA) empowers creators with Vocal, a platform strategically designed to drive value for the virtually infinite number of digital content creators.

Jerrick is a holding company focused on developing technology-based solutions. The company pursues a simple, straightforward mission: to provide creators with the technology and resources to get discovered and earn money to fund their creativity. The company achieves this mission through Vocal, its proprietary longform publishing platform equipped with…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$LXRP Expects Sustainable Revenue Growth, Plans New Capital Markets Strategy in 2020

• Growing interest in the company’s innovative DehydraTECH™ drug delivery platform from large global corporations
• Lexaria’s strategy to be listed on a nationally recognized U.S. exchange will help the company access a significantly larger audience of investors
• Lexaria has 16 patents with another 60 pending worldwide and is the only company to hold a patent for improved delivery of all non-psychoactive cannabinoids

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, has achieved virtually everything it set out to do in 2019 and has even bigger plans for 2020 that include achieving higher revenue and being listed on a major U.S. exchange, according to CEO Chris Bunka in a strategic update to shareholders (http://cnw.fm/hcA4X). While its shares remain “dramatically undervalued” at the moment, Bunka said, the company boasts a successful 2019 during which it signed different partnerships and agreements for use of its innovative DehydraTECH™ drug delivery platform.

The revolutionary drug delivery platform accelerates human intestinal cell absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sugars or sweeteners, and other unhealthy practices. It is applicable to a wide variety of bioactive substances, including cannabis and…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$SGLB President, CEO Discusses Disruptive 3D Metal-Printing Technology in NNW Interview

$LXRP Concerns About Vape Addiction, Injury Provide Lexaria with Opportunity

• Lexaria Bioscience continues to advance the effectiveness of its proprietary DehydraTECH technology, a formulation that teams with drug substances such as nicotine and cannabidiol to quickly carry those drugs into a user’s blood stream
• Recent concerns about the safety of vape products and ongoing concerns about the safety of tobacco are opening doors to Lexaria’s edible technology
• Newly legalized cannabis-infused edibles began hitting store shelves nationwide in Canada last month, presenting Lexaria with new potential licensing outlets for its increasingly effective products

If 2019 was the year when vape users discovered the potential perils of using untested off-brand products, 2020 may well be the year when vape users share the common woe of struggling to beat an addiction.

The U.S. Centers for Disease Control and Prevention (CDC) reported at year’s end that 2,561 people had been hospitalized with the vape-related lung illness now known as ‘e-cigarette or vaping product use-associated lung injury’ (EVALI) as of December 27, that the illness had afflicted every U.S. state and two territories, and……

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$JMDA CEO Details Company’s Patience, Discipline and Hard Work in Weekly Update

$LXRP South Dakota Governor Reconsiders Vetoing Hemp Law

South Dakota’s governor, Kristi Noem, is considering giving the go-ahead to the development of a hemp industry law as long as it meets her requirements. On Thursday, Noem announced that although she is not in favor of hemp, she would not oppose the bill if the legislature approves it and it meets her requirements. Speaking with KELO, Noem detailed her requirements of which she said that the crop must have stringent regulations and that the lawmakers should devise a way to pay for the hemp program.

The lawmakers have a draft bill ready and are planning to introduce it this week when the legislative sessions begin, said Lee Qualm, the House Majority Leader. He also added that the bill meets most of the requirements stated by Noem.

Some of the provisions in the draft bill that meet Noem’s requirements include the cultivation of hemp by farmers as long as they have a minimum of five acres, THC levels to be kept below 0.3%, and that the producers should have a license obtained from the state, as well as a hemp transportation permit.

Qualm further said that the current legislation has emergency clauses such that if it is approved, it would be effective immediately, allowing growers to participate in the spring’s planting season. However, he is not sure if the provision will be okayed. The federal department of agriculture would still need to approve the hemp plan, and this would leave the farmers with less than enough time to participate in the 2020 planting season.

The total cost of starting the hemp program would be $1.9 million, and an additional cost of maintaining the hemp program of $1.6 million, Noem’s office estimated. Noem also wants the fields and hemp facilities to be searched and inspected by law enforcement.

Last year, the governor took advantage of her power and vetoed the bill, and she planned on doing the same this year. Noem argued that legalizing hemp would be a gateway to marijuana legalization.

However, on Thursday, the governor announced a change of heart.

Although the Department of Agriculture in South Dakota had released guidelines for industrial hemp, South Dakota was one of the three states that did not approve hemp production because of the governor’s opposition. Some of the Indian tribes’ hemp plans are pending approval by the USDA, and the Flandreau Santee Sioux Tribe has already been authorized to grow hemp by the USDA. Meanwhile, South Dakota has had to permit interstate transportation of hemp in order to comply with federal law.

Experts think that the entire hemp industry, including sector players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and SinglePoint Inc. (OTCQB: SING), will be hoping that the state finally joins the rest of the country in enjoying the benefits that accrue from a legal hemp industry.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$TGODF Congress Will Again Debate Federal Marijuana Legalization this Week

January 14, 2020

Palm Beach, FL – January 14, 2020 — Cannabis is back in Congress.  Just months after the House Judiciary Committee approved the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, cannabis legalization will be the subject of another debate in and Commerce Subcommittee, reports Marijuana Moment.  “As public opinion continues to evolve and cannabis policies change at all levels of government, it’s important to bring federal agency officials together to discuss current and future federal cannabis policies,” Energy and Commerce Chairman Frank Pallone (D-NJ) and Health Subcommittee Chairwoman Anna Eshoo said. “We’re particularly interested in examining the implications of changing marijuana’s schedule listing, the potential of cannabis research, and federal efforts to review and approve cannabidiol products.”  As excitement builds for potential rescheduling, it’s creating sizable opportunity for companies including Terrace Global Inc. (TSX-V:TRCE), OrganiGram Holdings Inc. (NASDAQ:OGI)(TSX-V:OGI), The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF), Canopy Growth Corporation (TSX:WEED)(NYSE:CGC), and Charlotte’s Web Holdings Inc. (OTCQX:CWBHF) (CSE:CWEB).

Terrace Global Inc. (TSXV:TRCE) BREAKING NEWS: Terrace Global Inc. just announced that effective January 13, 2020, John Chou has been appointed as the Company’s Chief Financial Officer. John brings extensive expertise in financial reporting and in dealing with operations in emerging markets, having served in a number of senior roles in his over fifteen years of professional experience.  Previously, John was the Vice-President, Finance of Gran Colombia Gold Corp., a leading gold producer with operations in Colombia.  Prior to that John was the Vice-President, Finance of Frontera Energy Corp., a leading oil and gas producer in Colombia and previously a senior associate with Deloitte in Toronto.  “We are very pleased to have John join our team.  His global experience will be a key as for us as we grow our businesses internationally,” commented Francisco Ortiz von Bismarck.  “We would like to thank Leon Dadoun for his time with the Company and wish him every success going forward.”

Other cannabis-related developments from around the markets include:

OrganiGram Holdings Inc. (TSXV:OGI)(NASDAQ:OGI) announced the first of its ‘Cannabis 2.0’ products have been released, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges. Shipments of the custom-designed cartridges were sent to Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia, starting December 17, from the Company’s Moncton production campus. The first release from Organigram’s suite of vaporizer offerings affirms the Company’s commitment to supporting Canadians’ access to a variety of regulated recreational cannabis products. “As a company, bringing the next-generation of cannabis products to market without delay was important to us. We are proud to support access to tested, quality derivative-based products that we expect to help strengthen the regulated market and benefit those who prefer those product types over others,” said Greg Engel, CEO, Organigram. “Being one of the first licensed producers in the country ready to provide vape products, following the expiration of Health Canada’s 60-day notification period, illustrates that degree of focus and commitment. It speaks to an extraordinary effort by our internal teams who helped bring the Trailblazer Torch to market.”

The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF) announced changes to streamline its leadership structure. The Company’s President, Mr. Csaba Reider, will be departing the organization. Mr. Reider’s duties will be assumed by the Company’s CEO, Brian Athaide. Mike Gibbons, Vice President of Sales, is also leaving the organization. Robert Gora, Vice President of Medical Commercialization, will assume the consolidated role of Vice President, National Sales, leading sales and revenue generation across medical and recreational channels.  “The changes we announce today are part of a comprehensive review of our operations to reduce costs and improve cash flow. This will result in significant G&A savings and a leaner more efficient organization. We are also very focused on ramping up production, expanding our product portfolio with innovative organic products and gaining market share across the country.” commented Brian Athaide, CEO of TGOD.

Canopy Growth Corporation (TSX:WEED)(NYSE:CGC) announced that it will be working with a total of ten recently-announced Ontario retail license holders to open new Tokyo Smoke branded retail cannabis stores across the province. In addition to the five locations announced in November 2019, the following five locations are now progressing through the process to open doors in 2020: 1180 Queen Street West, Toronto, ON; 21 Bloor Street East, Toronto, ON; 235 James Street North, Hamilton, ON; 2257 Rymal Road East, Unit D-1, Stoney Creek, ON; 1000 Wellington Avenue Unit 101, Ottawa, ON. “With ten new stores set to open in the first half of this year, we are pleased with the momentum we’ve built and excited to bring the Tokyo Smoke experience to more Ontarians,” said Rade Kovacevic, President, Canopy Growth. “Increasing Tokyo Smoke’s presence across the province will expand access to high-quality cannabis products and education, continuing to migrate cannabis sales from the illicit to the regulated market.” Once licensed, this will bring the number of Tokyo Smoke branded retail cannabis stores in Ontario to a total of 12, joining Tokyo Smoke 333 Yonge at Dundas Square in Toronto, and Tokyo Smoke Oshawa. All ten of the new locations have been posted to the Alcohol and Gaming Commission of Ontario’s (“AGCO”) website and nine have completed the Public Notice period, progressing to the next stage in the licensing process.

Charlotte’s Web Holdings Inc. (OTCQX:CWBHF)(CSE:CWEB) announced that it has closed its previously announced underwritten public offering for aggregate gross proceeds to the Company of C$66,250,000. A total of 5,000,000 units of the Company, at a price of C$13.25 per Unit were sold pursuant to the Offering. The Offering was led by Canaccord Genuity Corp., together with a syndicate of underwriters including Cormark Securities Inc., Eight Capital, and PI Financial Corp. Each Unit was comprised of one common share of the Company and one half of one common share purchase warrant. Each Warrant will be exercisable to acquire one common share for a period of 2 years following the closing date of the Offering at an exercise price of C$16.50 per Warrant Share, subject to adjustment in certain events. Charlotte’s Web has also granted the Underwriters an option (the “Over-Allotment Option”) to purchase up to 750,000 additional Units of the Company on the same terms as the Offering, exercisable within 30 days of the closing of the Offering. Net proceeds from the Offering will be used primarily to fund the Company’s business development and for general working capital purposes. The Units were offered in each of the provinces of Canada, other than Québec, pursuant to the Company’s base shelf prospectus dated April 8, and were also offered by way of private placement in the United States to “qualified institutional buyers”. The terms of the Offering are described in a prospectus supplement dated November 27, 2019.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM was compensated thirty five hundred dollars for news coverage of current press releases issued by Terrace Global Inc., by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$SGLB Strives to Help Aerospace Manufacturers Overcome 3D Quality Manufacturing Problems

January 14, 2020

$POAI Disruptive Platform Overcoming Obstacles in Precision Medicine Industry

• The global precision medicine market is estimated to reach $84.6 billion by 2024
• Predictive Oncology is bringing cutting-edge technology to cancer research to develop highly customizable assessment methods that improve patient outcomes
• POAI leverages unique competitive advantage that stems from readily available access to historical data on tumor profiles and their drug responses

Precision medicine, an approach that seeks to understand the genetic makeup of a patient’s tumor in order to customize a drug targeting the particular gene type for each patient, offers tremendous potential for the treatment of a number of diseases. Predictive Oncology Inc. (NASDAQ: POAI), a data and artificial-intelligence-driven precision medicine company that develops models that predict tumor drug response, possesses a unique competitive advantage in this space, which Mordor Intelligence Inc. estimates will grow at a CAGR of 9.7%, reaching $84.6 billion by 2024 (http://nnw.fm/aLp0V).

Despite the industry’s optimistic outlook, technology used in precision medicine faces a serious obstacle due to the lack of available data to enable its application. Pharmaceutical companies have invested heavily in…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$LXRP DehydraTECH Platform Boosts CBD Absorption Levels

$GWPD Says that GrowPods May Help Farmers Reduce Financial Risk, Increase Quality Control

The ability to micro-manage crops in a Pod can help assure success by offering better control and risk mitigation

COLTON, Calif., Jan. 13, 2020 — GP Solutions (OTC:GWPD), the developer of modular controlled-environment micro-farms, says that GrowPods may help farmers reduce risk and increase quality control.

Crop failure can be devastating for large and small farms. Crop failure does not only occur in open fields – even in greenhouses and indoor cultivation facilities, crops can fail for a variety of reasons.

Weather certainly takes its toll on farms. Last Spring across the Midwest, torrential rains soaked fields, leaving the soil unsuitable for planting millions of acres.

Last May, the USDA announced that due to weather conditions, farmers had some of the lowest rates of planting in history. Some farmers declared a total crop loss.

Indoor farms are also susceptible to crop failure. Temperature, humidity, oxygen, watering and feeding cycles, and other factors need to be finely tuned to ensure a healthy crop. Additionally, male plants can accidentally pollinate and ruin an entire crop. And even in winter, some insects can find their way into a growroom and ravage a crop.

But with the GrowPod system, that risk is compartmentalized. Since the Pods are sealed, there is little chance of contamination. However, even if there is contamination, it can usually be contained within one pod and that risk is mitigated, causing significantly less damage than a crop problem could cost a producer who grows in a large open room or greenhouse.

With the ability to micromanage crops, there is a higher likelihood of success and better management of many potential issues that could be devastating in other growing conditions.

For more information, visit: www.growpodsolutions.com, or call: (855) 247-8054.

Forward-Looking Statements
This release includes predictions or information that might be considered “forward-looking” within securities laws. These statements represent Company’s current judgments, but are subject to uncertainties that could cause results to differ. Readers are cautioned to not place undue reliance on these statements, which reflect management’s opinions only as of the date of this release. The Company is not obligated to revise any statements in light of new information or events.

Connect:

Website: www.growpodsolutions.com

Facebook: facebook.com/GrowPodTechnology

Twitter: @GrowPodSolution

$JMDA Developed Proprietary Technology to Power its Best-In-Class Creator Platform

January 13, 2020

$YGYI South Carolina Threatens to Crackdown on Companies Making Pet and Animal CBD Feeds

$SRAX Releases Results of Holiday Shopping Study, Demonstrates Power of BIGtoken Platform

• SRAX’s pre-Thanksgiving BIGtoken survey of 116,000-plus American consumers found 28% planned to shop in store, 40% online and 32% both
• SRAX COO said company’s 2019 Holiday Spending Report demonstrates power of proprietary platform to gather insights from specific audiences
• SRAX has access to BIGtoken platform audience of more than 16 million, 100% opt-in consumers

SRAX Inc. (NASDAQ: SRAX) is revealing the potential of its platform’s data, having recently released the results of its 2019 Holiday Spending Report – a survey of 116,000 American consumers (http://nnw.fm/UYQi3). SRAX COO Kristoffer Nelson said SRAX’s BIGresearch survey demonstrates the power of its proprietary BIGtoken platform and the Company’s ability to offer timely and accurate research from specific audiences.

The survey showed that 28% of American consumers polled planned to holiday shop in stores, while 40% planned online purchases and 32% said they would buy both in store and online. Results from the 2019 Holiday Spending Report by SRAX also breaks down results by gender, age, ethnicity and…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$POAI to Create World’s First Comprehensive, Actionable Multi-Omic Data Set for Ovarian Cancer

• POAI plans to have first predictive model of ovarian cancer ready for initial commercialization in Q1 2020
• First batch of 400 ovarian cancer subjects in initiative has been sequenced
• Groundbreaking AI-driven model of ovarian cancer will be capable of predicting tumor drug response, patient outcome

Predictive Oncology Inc. (NASDAQ: POAI), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has updated the commercialization of its pioneering CancerQuest 2020 initiative (http://nnw.fm/y6fnc). Based on the updated announcement, the company plans on having its first predictive model of ovarian cancer ready for initial commercialization in revenue-generating projects with Pharma in Q1 2020.

POAI’s CancerQuest 2020 initiative has been driven Helomics, a Predictive Oncology subsidiary which has worked closely with collaborators at the University of Pittsburgh Medical Center (UPMC)-Magee Women’s Hospital to optimize and scale the genomic and transcriptomic data that has been gathered. The first batch of the 400 ovarian cancer subjects has…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$LXRP CEO Posts Strategic Company Update